Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
American Journal of Nephrology|January 1, 1990
Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patientsP A Abraham, J A Opsahl, K M Rachael, et al.The American Journal of Physiology|April 8, 1998
Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophyL J Heller, J A Opsahl, S E Wernsing, et al.Hypertension (Dallas, Tex. : 1979)|August 1, 1997
Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardiumS A Katz, J A Opsahl, M M Lunzer, et al.Journal of Clinical Pharmacology|February 1, 1995
Effects of hemodialysis on plasma protein binding of bepridilJ F Pritchard, G R Matzke, J A Opsahl, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 1, 1993
Renin and renin inhibition in anephric manJ A Opsahl, K L Smith, R D Murray, et al.Journal of Proteomics|November 30, 2010
Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomicsA C Kroksveen, J A Opsahl, T T Aye, et al.American Journal of Nephrology|January 1, 1988
Suprofen-induced uricosuria. A potential mechanism for acute nephropathy and flank painP A Abraham, C E Halstenson, J A Opsahl, et al.Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controlsA C Kroksveen, A Guldbrandsen, C Vedeler, et al.Antimicrobial Agents and Chemotherapy|February 1, 1992
Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteersD R Guay, J A Opsahl, F G McMahon, et al.Pageof 6